YDL196W Antibody

What is YDL196W antibody and what organisms does it target?

YDL196W antibody is a rabbit polyclonal antibody specifically targeting the putative uncharacterized protein YDL196W from Saccharomyces cerevisiae (Baker's yeast), strain 204508/S288c. This antibody recognizes a protein with a molecular weight of approximately 12,905 Da and is generated using recombinant Saccharomyces cerevisiae YDL196W protein as the immunogen . The antibody is typically in liquid form with preservatives including 0.03% Proclin 300, 50% Glycerol, and 0.01M PBS at pH 7.4 .

What are the validated applications for YDL196W antibody?

Based on available research data, YDL196W antibody has been tested and validated for the following applications:

• ELISA (Enzyme-Linked Immunosorbent Assay)

• Western Blot (WB)

These applications enable researchers to detect and quantify the presence of the YDL196W protein in yeast samples, which is crucial for studies involving gene expression, protein localization, and functional characterization .

What are the recommended storage and handling conditions for YDL196W antibody?

For optimal preservation of antibody activity:

• Store at -20°C or -80°C upon receipt

• Avoid repeated freeze-thaw cycles

• If the antibody becomes entrapped in the seal during shipment or storage, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container's cap

• Certain products may require shipping with dry ice and additional dry ice fees may apply

Proper storage and handling ensure the antibody maintains its specificity and binding efficiency throughout your research project .

How should I validate the specificity of YDL196W antibody in my experiments?

Comprehensive validation requires a multi-pronged approach:

• Western Blot Analysis:

  • Compare wild-type yeast extracts (positive control) with YDL196W deletion strain extracts (negative control)

  • Confirm single band detection at approximately 12,905 Da

  • Include recombinant YDL196W protein as additional positive control

• Immunoprecipitation Followed by Mass Spectrometry:

  • Perform pull-down experiments using the antibody

  • Analyze precipitated proteins by mass spectrometry

  • Confirm enrichment of YDL196W peptides

• Epitope Competition Assays:

  • Pre-incubate antibody with excess recombinant YDL196W protein

  • Apply to samples in parallel with non-competed antibody

  • Specific binding should be significantly reduced in the competed samples

These validation steps ensure your experimental results truly reflect YDL196W presence rather than non-specific interactions .

What is the optimal protocol for using YDL196W antibody in Western blotting?

For optimal Western blot results with YDL196W antibody:

• Sample Preparation:

  • Extract proteins from yeast cells using glass bead lysis or enzymatic methods

  • Include protease inhibitors to prevent degradation

  • Denature proteins in standard SDS-PAGE loading buffer

• Gel Electrophoresis and Transfer:

  • Use 12-15% acrylamide gels due to the small size of YDL196W (12,905 Da)

  • Transfer to PVDF or nitrocellulose membranes at 100V for 1 hour or 30V overnight

• Antibody Incubation:

  • Block with 5% non-fat dry milk or BSA in TBST

  • Dilute primary antibody according to manufacturer's recommendations

  • Incubate overnight at 4°C with gentle agitation

  • Use HRP-conjugated anti-rabbit IgG as secondary antibody

• Detection and Imaging:

  • Use enhanced chemiluminescence (ECL) detection systems

  • Optimize exposure time based on signal strength

  • Document with digital imaging systems for quantitative analysis

This protocol may require optimization based on your specific experimental conditions and antibody batch characteristics .

How can I integrate YDL196W antibody into protein array studies?

Based on reverse-phase protein array (RPPA) methodologies, researchers can effectively incorporate YDL196W antibody into array-based studies:

• Sample Preparation:

  • Prepare standardized yeast lysates under various experimental conditions

  • Create serial dilutions to ensure quantitative analysis

  • Include appropriate controls (wild-type, deletion mutants, etc.)

• Array Printing and Processing:

  • Print samples in an ordered array on nitrocellulose-coated glass slides

  • Process slides with validated YDL196W antibody at optimized concentration

  • Include technical replicates for statistical confidence

• Data Analysis:

  • Implement Python command-line tools for normalization and quality control

  • Perform statistical analysis to compare expression levels across conditions

  • Validate findings with orthogonal methods (Western blot, immunoprecipitation)

This approach allows high-throughput analysis of YDL196W expression across multiple experimental conditions simultaneously, providing robust quantitative data .

What are common issues when working with YDL196W antibody and how can they be resolved?

Systematic troubleshooting using this approach can help resolve most technical issues encountered with YDL196W antibody applications .

How should contradictory results between different applications be interpreted?

When faced with discrepancies between applications (e.g., positive Western blot but negative ELISA):

• Technical Validation:

  • Verify antibody specificity in each application

  • Assess whether epitope accessibility differs between applications

  • Test different sample preparation methods that might affect epitope exposure

• Cross-validation Approaches:

  • Confirm findings using orthogonal detection methods

  • If possible, use YDL196W-tagged constructs and detect with tag-specific antibodies

  • Implement genetic approaches (knockout/knockdown) to validate specificity

• Biological Explanations to Consider:

  • Post-translational modifications might affect antibody recognition

  • Protein conformation changes under different experimental conditions

  • Protein complex formation may mask epitopes in certain applications

By systematically investigating discrepancies, you can determine whether contradictions arise from technical issues or reflect genuine biological complexity .

What controls should be included in YDL196W antibody experiments?

A comprehensive control strategy includes:

• Positive Controls:

  • Wild-type yeast strains expressing YDL196W

  • Recombinant YDL196W protein at known concentrations

  • Previously validated positive samples

• Negative Controls:

  • YDL196W deletion or knockout strains

  • Secondary antibody-only samples (omit primary antibody)

  • Isotype controls (non-specific rabbit IgG at same concentration)

• Specificity Controls:

  • Pre-absorption controls (pre-incubate antibody with excess antigen)

  • Competing peptide controls

  • Antibody dilution series to demonstrate signal specificity

• Technical Controls:

  • Loading controls for Western blots (e.g., housekeeping proteins)

  • Internal reference standards for quantitative applications

  • Technical replicates to assess reproducibility

These controls provide confidence that observed signals are specific to YDL196W and not artifacts of the experimental procedure .

How can machine learning approaches enhance YDL196W antibody experiments?

Recent advances in antibody engineering demonstrated in the DyAb model show promising applications for research antibodies like YDL196W:

• Sequence-Based Optimization:

  • Apply deep mutational scanning to identify affinity-enhancing mutations

  • Use pre-trained language models (like AntiBERTy or LBSTER mentioned in the research) to predict improved variants

  • Implement genetic algorithms to select and combine beneficial mutations

• Predictive Performance Analysis:

  • Train regression models to predict binding affinity changes (ΔpKD)

  • Use embedding-based models to score potential antibody designs

  • Apply these techniques to generate higher-affinity YDL196W antibody variants

• Data Analysis Enhancement:

  • Develop automated image analysis pipelines for microscopy-based experiments

  • Implement machine learning for pattern recognition in complex datasets

  • Use clustering algorithms to identify experimental conditions with similar outcomes

The DyAb research demonstrates that such approaches can yield significant improvements in antibody performance, with binding improvements of 3-50 fold compared to parent antibodies .

What are the considerations for adapting YDL196W antibody for proximity labeling studies?

To implement proximity labeling with YDL196W antibody:

• Antibody-Enzyme Fusion Strategy:

  • Conjugate YDL196W antibody to proximity labeling enzymes such as:

    • APEX2 (engineered ascorbate peroxidase)

    • BioID or TurboID (biotin ligase variants)

  • Validate construct specificity and labeling activity

• Implementation Protocol:

  • Introduce the antibody-enzyme construct into yeast cells

  • Add appropriate labeling substrate

  • Allow proximity labeling to occur (minutes to hours)

  • Purify biotinylated proteins using streptavidin beads

  • Identify labeled proteins by mass spectrometry

• Data Analysis Considerations:

  • Compare labeled proteome to appropriate controls

  • Filter out common contaminants

  • Validate interactions with orthogonal methods

  • Create interaction network maps

This approach would allow mapping of the local interactome of YDL196W in intact cells, providing insights into its functional associations and potential role in yeast cellular processes .

How can quantitative data from YDL196W experiments be rigorously analyzed?

For robust quantitative analysis:

• Western Blot Quantification:

  • Use specialized software (ImageJ, Image Lab) to quantify band intensity

  • Normalize to loading controls

  • Include technical and biological replicates (minimum n=3)

  • Apply appropriate statistical tests (t-test, ANOVA)

• ELISA Data Analysis:

  • Generate standard curves using purified recombinant YDL196W

  • Ensure linearity in the working range

  • Apply 4 or 5-parameter logistic curve fitting

  • Report both raw and normalized values

• Protein Array Data Processing:

  • Implement Python-based analysis pipelines for normalization and QC

  • Apply appropriate background subtraction methods

  • Use positive controls for inter-assay normalization

  • Account for batch effects

• Statistical Considerations:

  • Control for multiple hypothesis testing when analyzing large datasets

  • Use appropriate visualization methods

  • Distinguish between statistical and biological significance

  • Report effect sizes alongside p-values

Proper data analysis ensures reliable interpretation of YDL196W expression or interaction studies and supports reproducible research .

How might new antibody engineering techniques improve YDL196W antibody performance?

Based on recent advancements in antibody engineering described in the DyAb research:

• Complementarity-Determining Region (CDR) Optimization:

  • Perform deep mutational scanning of CDRs

  • Combine beneficial mutations using genetic algorithms

  • Select variants with improved affinity and specificity

• Experimental Validation Approach:

  • Express engineered variants in mammalian cells as described in the DyAb research

  • Measure binding kinetics using surface plasmon resonance (SPR)

  • Assess specificity using multiple experimental approaches

  • Incorporate successful designs into subsequent optimization rounds

• Expected Improvements:

  • Higher binding affinity (potentially 3-50 fold improvements as seen in DyAb research)

  • Improved specificity for target protein

  • Better signal-to-noise ratio in experimental applications

The systematic approach described in the DyAb paper produced antibodies with significantly enhanced properties while maintaining high expression rates and target specificity, suggesting similar strategies could be applied to improve YDL196W antibody .

What bioinformatic approaches can enhance YDL196W protein characterization?

To better understand the currently "putative uncharacterized" YDL196W protein:

• Sequence Analysis Tools:

  • Apply BLAST, Clustal Omega for homology identification

  • Use structure prediction tools (PSIPRED, SWISS-MODEL)

  • Identify functional domains and motifs (InterPro, Pfam)

• Integration with Existing Datasets:

  • Map YDL196W to yeast transcriptomic and proteomic datasets

  • Utilize the Saccharomyces Genome Database (SGD) for contextual information

  • Perform GO term enrichment analysis for functional insights

• Network Analysis:

  • Map YDL196W into protein-protein interaction networks

  • Identify potential functional associations based on network position

  • Predict biological roles based on interaction partners

• Custom Analysis Pipelines:

  • Develop Python-based tools for:

    • Cross-experiment data integration

    • Pathway analysis

    • Visualization of complex datasets

    • Statistical evaluation of experimental results

These bioinformatic approaches can provide valuable context for interpreting experimental findings and guide future research directions for YDL196W characterization .

What experimental approaches could determine the function of currently uncharacterized YDL196W?

Given that YDL196W is described as a "putative uncharacterized protein" located in the promoter region of SEC31, these experimental strategies could elucidate its function:

• Genetic Approaches:

  • Create precise deletion and overexpression strains

  • Perform phenotypic screening under various conditions

  • Conduct synthetic genetic array analysis to identify genetic interactions

  • Implement CRISPR-based genetic screens

• Biochemical Characterization:

  • Purify the protein and determine its structure

  • Assess potential enzymatic activities

  • Identify post-translational modifications

  • Determine subcellular localization using YDL196W antibody

• Transcriptomic and Proteomic Impact:

  • Analyze gene expression changes upon YDL196W deletion/overexpression

  • Perform proteome-wide studies with and without YDL196W

  • Focus on SEC31 expression and regulation given the noted proximity

• Chromatin Association Studies:

  • Use ChIP-seq with YDL196W antibody to identify potential DNA binding sites

  • Assess impact on chromatin structure and accessibility

  • Investigate potential role in transcriptional regulation of SEC31